American International Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

American International Group’s Portfolio PHAS Stock Details PHAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,891	Closed	-$31	–	3351
2021 Q1	$31	Buy	8,891 +24	+0.3%	+$97	﹤0.01%	3083
2020 Q4	$30	Sell	8,867 -255	-3%	-$913	﹤0.01%	3051
2020 Q3	$32K	Sell	9,122 -28	-0.3%	-$113	﹤0.01%	2994
2020 Q2	$42K	Buy	9,150 +1,027	+13%	+$4.55K	﹤0.01%	2939
2020 Q1	$27K	Sell	8,123 -469	-5%	-$2.15K	﹤0.01%	2877
2019 Q4	$52K	Sell	8,592 -72	-0.8%	-$297	﹤0.01%	2872
2019 Q3	$36K	Sell	8,664 -61	-0.7%	-$486	﹤0.01%	2963
2019 Q2	$115K	Buy	+8,725	New	+$107K	﹤0.01%	2603

Other funds holding PHAS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

American International Group's PHAS Position: Q2 2021 in Review

American International Group sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q2 2021, closing a stake of 8,891 shares — an estimated $31 sold.

American International Group first reported a position in PHAS in Q2 2019 and held it in 8 quarters. The position peaked at $115K in Q2 2019. 55 funds tracked by Wall St. Rank hold PHAS as of Q2 2021.

American International Group reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
American International Group sold 8,891 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $31.
American International Group first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
American International Group's PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $115K in Q2 2019.
55 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.